1. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines;Ain,1997
2. Novel targeted therapies for metastatic thyroid cancer-A comprehensive review;Al-Jundi,2020
3. Dabrafenib versus Dabrafenib + trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: results of a randomized, phase 2, open-label multicenter trial;Busaidy,2022
4. c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition;Byeon,2016
5. Thyroid cancer;Cabanillas,2016